Published in Cancer Epidemiol Biomarkers Prev on February 01, 2010
Quality of life in MAP.3 (Mammary Prevention 3): a randomized, placebo-controlled trial evaluating exemestane for prevention of breast cancer. J Clin Oncol (2014) 2.25
Factors affecting uptake and adherence to breast cancer chemoprevention: a systematic review and meta-analysis. Ann Oncol (2015) 2.17
Use of tamoxifen and raloxifene for breast cancer chemoprevention in 2010. Breast Cancer Res Treat (2012) 1.66
Future directions in cancer prevention. Nat Rev Cancer (2012) 1.62
Long-term outcomes of BRCA1/BRCA2 testing: risk reduction and surveillance. Cancer (2011) 1.41
Benign breast disease, mammographic breast density, and the risk of breast cancer. J Natl Cancer Inst (2013) 1.34
Women's interest in taking tamoxifen and raloxifene for breast cancer prevention: response to a tailored decision aid. Breast Cancer Res Treat (2011) 1.16
Molecular pathology in epidemiologic studies: a primer on key considerations. Cancer Epidemiol Biomarkers Prev (2010) 1.14
Uptake of tamoxifen in consecutive premenopausal women under surveillance in a high-risk breast cancer clinic. Br J Cancer (2014) 1.01
Current strategies for the prevention of breast cancer. Breast Cancer (Dove Med Press) (2014) 0.93
An intermittent approach for cancer chemoprevention. Nat Rev Cancer (2011) 0.92
Recent changes in endometrial cancer trends among menopausal-age U.S. women. Cancer Epidemiol (2013) 0.91
Acceptance and adherence to chemoprevention among women at increased risk of breast cancer. Breast (2014) 0.90
Tamoxifen augments the innate immune function of neutrophils through modulation of intracellular ceramide. Nat Commun (2015) 0.90
Premenopausal serum androgens and breast cancer risk: a nested case-control study. Breast Cancer Res (2012) 0.89
Oral low dose and topical tamoxifen for breast cancer prevention: modern approaches for an old drug. Breast Cancer Res (2012) 0.87
Development of a personalized decision aid for breast cancer risk reduction and management. BMC Med Inform Decis Mak (2014) 0.86
The manner in which calories are restricted impacts mammary tumor cancer prevention. J Carcinog (2011) 0.85
Exemestane for breast cancer prevention: a critical shift? Cancer Discov (2012) 0.85
Effects of tomato- and soy-rich diets on the IGF-I hormonal network: a crossover study of postmenopausal women at high risk for breast cancer. Cancer Prev Res (Phila) (2011) 0.82
Tamoxifen vs Raloxifene vs Exemestane for Chemoprevention. Curr Breast Cancer Rep (2012) 0.82
Uptake of a randomized breast cancer prevention trial comparing letrozole to placebo in BRCA1/2 mutations carriers: the LIBER trial. Fam Cancer (2012) 0.82
Breast Cancer Chemoprevention among High-risk Women and those with Ductal Carcinoma In Situ. Breast J (2015) 0.81
My Lived Experiences Are More Important Than Your Probabilities: The Role of Individualized Risk Estimates for Decision Making about Participation in the Study of Tamoxifen and Raloxifene (STAR). Med Decis Making (2015) 0.80
Affective forecasting and medication decision making in breast-cancer prevention. Health Psychol (2016) 0.79
Awareness of preventive medication among women at high risk for breast cancer and their willingness to consider transdermal or oral tamoxifen: a focus group study. BMC Cancer (2015) 0.79
Estimating the risks and benefits of tamoxifen for prophylactic breast cancer chemoprevention in Korea. J Breast Cancer (2012) 0.79
Current treatment of early breast cancer: adjuvant and neoadjuvant therapy. F1000Res (2014) 0.78
Barriers to preventive therapy for breast and other major cancers and strategies to improve uptake. Ecancermedicalscience (2015) 0.77
Symptoms and QOL as Predictors of Chemoprevention Adherence in NRG Oncology/NSABP Trial P-1. J Natl Cancer Inst (2015) 0.76
Clinical utilities of aromatase inhibitors in breast cancer. Int J Womens Health (2015) 0.76
Chemoprevention of Breast Cancer: The Paradox of Evidence versus Advocacy Inaction. Cancers (Basel) (2012) 0.76
Potential Mechanisms underlying the Protective Effect of Pregnancy against Breast Cancer: A Focus on the IGF Pathway. Front Oncol (2016) 0.75
Decision making for breast cancer prevention among women at elevated risk. Breast Cancer Res (2017) 0.75
An Effective Multimodal Curriculum to Teach Internal Medicine Residents Evidence-Based Breast Health. J Grad Med Educ (2014) 0.75
Combination of Antiestrogens and Omega-3 Fatty Acids for Breast Cancer Prevention. Biomed Res Int (2015) 0.75
Establishing a program for individuals at high risk for breast cancer. J Cancer (2013) 0.75
Prevalence of chemopreventive agent use among hospitalised women at high risk for breast cancer: a cross-sectional study. BMJ Open (2016) 0.75
Uptake of exemestane chemoprevention in postmenopausal women at increased risk for breast cancer. Eur J Cancer Prev (2016) 0.75
Cancer Prevention: Lessons Learned and Future Directions. Trends Cancer (2016) 0.75
Hormone Replacement Therapy, Likely Neither Angel Nor Demon. PLoS One (2015) 0.75
Women's preferences for selective estrogen reuptake modulators: an investigation using the time trade-off technique. Springerplus (2014) 0.75
How do we increase uptake of tamoxifen and other anti-estrogens for breast cancer prevention? NPJ Breast Cancer (2017) 0.75
Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst (1998) 22.10
Weighing the risks and benefits of tamoxifen treatment for preventing breast cancer. J Natl Cancer Inst (1999) 6.60
Overview of the main outcomes in breast-cancer prevention trials. Lancet (2003) 4.31
Using a drug facts box to communicate drug benefits and harms: two randomized trials. Ann Intern Med (2009) 3.44
Estimates of the number of US women who could benefit from tamoxifen for breast cancer chemoprevention. J Natl Cancer Inst (2003) 2.48
The impact of the format of graphical presentation on health-related knowledge and treatment choices. Patient Educ Couns (2008) 2.42
Patient reluctance toward tamoxifen use for breast cancer primary prevention. Ann Surg Oncol (2001) 1.94
Alternate methods of framing information about medication side effects: incremental risk versus total risk of occurrence. J Health Commun (2008) 1.65
Communicating side effect risks in a tamoxifen prophylaxis decision aid: the debiasing influence of pictographs. Patient Educ Couns (2008) 1.60
Reducing aversion to side effects in preventive medical treatment decisions. J Exp Psychol Appl (2007) 1.52
"If I'm better than average, then I'm ok?": Comparative information influences beliefs about risk and benefits. Patient Educ Couns (2007) 1.51
Preferences of Women Evaluating Risks of Tamoxifen (POWER) study of preferences for tamoxifen for breast cancer risk reduction. Cancer (2005) 1.43
Tamoxifen for breast cancer chemoprevention: low uptake by high-risk women after evaluation of a breast lump. Ann Fam Med (2005) 1.28
Women's views on chemoprevention of breast cancer: qualitative study. Can Fam Physician (2006) 1.21
Factors affecting breast cancer risk reduction practices among California physicians. Prev Med (2004) 1.14
"I'm going to die of something anyway": women's perceptions of tamoxifen for breast cancer risk reduction. Ethn Dis (2005) 1.04
Explanations for side effect aversion in preventive medical treatment decisions. Health Psychol (2009) 1.01
The relationship among physicians' specialty, perceptions of the risks and benefits of adjuvant tamoxifen therapy, and its recommendation in older patients with breast cancer. Med Care (2004) 0.94
Excess deaths associated with underweight, overweight, and obesity. JAMA (2005) 22.17
Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis. JAMA (2013) 18.86
Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med (2005) 16.70
Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst (2004) 14.97
The decrease in breast-cancer incidence in 2003 in the United States. N Engl J Med (2007) 12.23
Cause-specific excess deaths associated with underweight, overweight, and obesity. JAMA (2007) 11.50
Annual Report to the Nation on the Status of Cancer, 1975-2009, featuring the burden and trends in human papillomavirus(HPV)-associated cancers and HPV vaccination coverage levels. J Natl Cancer Inst (2013) 8.75
Meat intake and mortality: a prospective study of over half a million people. Arch Intern Med (2009) 6.42
Prevalence of oral HPV infection in the United States, 2009-2010. JAMA (2012) 6.02
Comparisons of percentage body fat, body mass index, waist circumference, and waist-stature ratio in adults. Am J Clin Nutr (2008) 5.01
Prospective study of serum vitamin D and cancer mortality in the United States. J Natl Cancer Inst (2007) 4.89
Effects of mammography screening under different screening schedules: model estimates of potential benefits and harms. Ann Intern Med (2009) 4.60
How numeracy influences risk comprehension and medical decision making. Psychol Bull (2009) 4.22
Detectable clonal mosaicism and its relationship to aging and cancer. Nat Genet (2012) 3.69
Nonsteroidal anti-inflammatory drug use, chronic liver disease, and hepatocellular carcinoma. J Natl Cancer Inst (2012) 3.69
Eating out in America, 1987-2000: trends and nutritional correlates. Prev Med (2004) 3.55
Metabolic syndrome increases the risk of primary liver cancer in the United States: a study in the SEER-Medicare database. Hepatology (2011) 3.24
High adiposity and high body mass index-for-age in US children and adolescents overall and by race-ethnic group. Am J Clin Nutr (2010) 3.22
Methods of calculating deaths attributable to obesity. Am J Epidemiol (2004) 3.15
Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control study. Clin Gastroenterol Hepatol (2007) 2.90
Population-attributable fractions of risk factors for hepatocellular carcinoma in the United States. Am J Gastroenterol (2013) 2.89
Insulin, glucose, insulin resistance, and pancreatic cancer in male smokers. JAMA (2005) 2.71
Body mass index categories in observational studies of weight and risk of death. Am J Epidemiol (2014) 2.62
Trends in colorectal cancer test use among vulnerable populations in the United States. Cancer Epidemiol Biomarkers Prev (2011) 2.62
Improved estimates of cancer-specific survival rates from population-based data. J Natl Cancer Inst (2010) 2.59
Evaluation of the American Stop Smoking Intervention Study (ASSIST): a report of outcomes. J Natl Cancer Inst (2003) 2.54
Trends in black-white differentials in dietary intakes of U.S. adults, 1971-2002. Am J Prev Med (2007) 2.52
Estimates of the number of US women who could benefit from tamoxifen for breast cancer chemoprevention. J Natl Cancer Inst (2003) 2.48
Secular trends in patterns of self-reported food consumption of adult Americans: NHANES 1971-1975 to NHANES 1999-2002. Am J Clin Nutr (2006) 2.40
Dietary patterns and adenocarcinoma of the esophagus and distal stomach. Am J Clin Nutr (2002) 2.40
Risk of heart failure in breast cancer patients after anthracycline and trastuzumab treatment: a retrospective cohort study. J Natl Cancer Inst (2012) 2.21
Impact of cancer on health-related quality of life of older Americans. J Natl Cancer Inst (2009) 2.20
Confirmation of family cancer history reported in a population-based survey. J Natl Cancer Inst (2011) 2.13
Secular trends in the association of socio-economic position with self-reported dietary attributes and biomarkers in the US population: National Health and Nutrition Examination Survey (NHANES) 1971-1975 to NHANES 1999-2002. Public Health Nutr (2007) 2.07
Blood lead levels and death from all causes, cardiovascular disease, and cancer: results from the NHANES III mortality study. Environ Health Perspect (2006) 2.07
Breast cancer incidence rates in U.S. women are no longer declining. Cancer Epidemiol Biomarkers Prev (2011) 2.06
Data and trends in cancer screening in the United States: results from the 2005 National Health Interview Survey. Cancer (2010) 2.05
Age-conditional probabilities of developing cancer. Stat Med (2003) 2.03
Benefit/risk assessment for breast cancer chemoprevention with raloxifene or tamoxifen for women age 50 years or older. J Clin Oncol (2011) 2.00
Reverse causation and illness-related weight loss in observational studies of body weight and mortality. Am J Epidemiol (2010) 1.99
A large prospective study of meat consumption and colorectal cancer risk: an investigation of potential mechanisms underlying this association. Cancer Res (2010) 1.98
An application of a weighting method to adjust for nonresponse in standardized incidence ratio analysis of cohort studies. Ann Epidemiol (2005) 1.96
Risk factors for human herpesvirus 8 infection among adults in the United States and evidence for sexual transmission. J Infect Dis (2007) 1.88
Which women aren't getting mammograms and why? (United States). Cancer Causes Control (2007) 1.85
Physician use of genetic testing for cancer susceptibility: results of a national survey. Cancer Epidemiol Biomarkers Prev (2003) 1.83
Serum levels of vitamin D metabolites and breast cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer Epidemiol Biomarkers Prev (2008) 1.80
Estimates of excess deaths associated with body mass index and other anthropometric variables. Am J Clin Nutr (2009) 1.73
An investigation of risk factors for renal cell carcinoma by histologic subtype in two case-control studies. Int J Cancer (2013) 1.71
A sustained decline in postmenopausal hormone use: results from the National Health and Nutrition Examination Survey, 1999-2010. Obstet Gynecol (2012) 1.67
Use of tamoxifen and raloxifene for breast cancer chemoprevention in 2010. Breast Cancer Res Treat (2012) 1.66
Dietary patterns predict mortality in a national cohort: the National Health Interview Surveys, 1987 and 1992. J Nutr (2004) 1.64
Intakes of plain water, moisture in foods and beverages, and total water in the adult US population--nutritional, meal pattern, and body weight correlates: National Health and Nutrition Examination Surveys 1999-2006. Am J Clin Nutr (2009) 1.64
Hypertension and risk of renal cell carcinoma among white and black Americans. Epidemiology (2011) 1.61
Changing patterns in breast cancer incidence trends. J Natl Cancer Inst Monogr (2006) 1.61
Large prospective investigation of meat intake, related mutagens, and risk of renal cell carcinoma. Am J Clin Nutr (2011) 1.60
Statistical methods in the Global Enteric Multicenter Study (GEMS). Clin Infect Dis (2012) 1.59
Contributors of water intake in US children and adolescents: associations with dietary and meal characteristics--National Health and Nutrition Examination Survey 2005-2006. Am J Clin Nutr (2010) 1.55
Increasing incidence of testicular germ cell tumors among black men in the United States. J Clin Oncol (2005) 1.55
Correcting bias, or biased corrections? Obesity (Silver Spring) (2008) 1.54
Cigarette smoking and renal cell carcinoma risk among black and white Americans: effect modification by hypertension and obesity. Cancer Epidemiol Biomarkers Prev (2012) 1.54
Socioeconomic status, healthcare density, and risk of prostate cancer among African American and Caucasian men in a large prospective study. Cancer Causes Control (2012) 1.52
Risk factors for inflammatory breast cancer and other invasive breast cancers. J Natl Cancer Inst (2013) 1.48
Impact of smoking and preexisting illness on estimates of the fractions of deaths associated with underweight, overweight, and obesity in the US population. Am J Epidemiol (2007) 1.46
Understanding the factors underlying disparities in cancer screening rates using the Peters-Belson approach: results from the 1998 National Health Interview Survey. Med Care (2004) 1.46
Strengthening the reporting of Genetic RIsk Prediction Studies (GRIPS): explanation and elaboration. J Clin Epidemiol (2011) 1.46
Neighborhood socioeconomic deprivation and mortality: NIH-AARP diet and health study. PLoS One (2010) 1.44
A comparison of three dietary pattern indexes for predicting biomarkers of diet and disease. J Am Coll Nutr (2005) 1.44
Dairy, calcium, and vitamin D intakes and prostate cancer risk in the National Health and Nutrition Examination Epidemiologic Follow-up Study cohort. Am J Clin Nutr (2005) 1.43
A combined healthy lifestyle score and risk of pancreatic cancer in a large cohort study. Arch Intern Med (2009) 1.42
Aspirin use and mortality from cancer in a prospective cohort study. Anticancer Res (2004) 1.40
The use of modeling to understand the impact of screening on U.S. mortality: examples from mammography and PSA testing. Stat Methods Med Res (2004) 1.39
Prevalence and correlates of repeat mammography among women aged 55-79 in the Year 2000 National Health Interview Survey. Prev Med (2004) 1.39
Health status, neighborhood socioeconomic context, and premature mortality in the United States: The National Institutes of Health-AARP Diet and Health Study. Am J Public Health (2011) 1.39
Building the evidence base for decision making in cancer genomic medicine using comparative effectiveness research. Genet Med (2012) 1.39
What factors are associated with diagnostic follow-up after abnormal mammograms? Findings from a U.S. National Survey. Cancer Epidemiol Biomarkers Prev (2004) 1.36
Awareness of genetic testing for increased cancer risk in the year 2000 National Health Interview Survey. Community Genet (2003) 1.36
Alcoholic beverage consumption, nutrient intakes, and diet quality in the US adult population, 1999-2006. J Am Diet Assoc (2010) 1.36
Non-steroidal anti-inflammatory drugs and colorectal cancer risk in a large, prospective cohort. Am J Gastroenterol (2011) 1.34
Dietary saturated fat intake is inversely associated with bone density in humans: analysis of NHANES III. J Nutr (2006) 1.34
Meat and meat-related compounds and risk of prostate cancer in a large prospective cohort study in the United States. Am J Epidemiol (2009) 1.34
Communication of uncertainty regarding individualized cancer risk estimates: effects and influential factors. Med Decis Making (2010) 1.33
Trends in the use of aspirin and nonsteroidal anti-inflammatory drugs in the general U.S. population. Pharmacoepidemiol Drug Saf (2013) 1.33
Prospective study of alcohol consumption in the United States: quantity, frequency, and cause-specific mortality. Alcohol Clin Exp Res (2008) 1.32
Relationship of benign gynecologic diseases to subsequent risk of ovarian and uterine tumors. Cancer Epidemiol Biomarkers Prev (2005) 1.32
Women's experiences with genomic testing for breast cancer recurrence risk. Cancer (2010) 1.29
Socioeconomic status and the risk of colorectal cancer: an analysis of more than a half million adults in the National Institutes of Health-AARP Diet and Health Study. Cancer (2012) 1.27
Population prevalence of familial cancer and common hereditary cancer syndromes. The 2005 California Health Interview Survey. Genet Med (2010) 1.26
Persistent organochlorine pesticides and risk of testicular germ cell tumors. J Natl Cancer Inst (2008) 1.23
Nutrient intakes and adenocarcinoma of the esophagus and distal stomach. Nutr Cancer (2002) 1.23
The frequency of ipsilateral second tumors after breast-conserving surgery for DCIS: a population based analysis. Cancer (2005) 1.22
Use of imputed population-based cancer registry data as a method of accounting for missing information: application to estrogen receptor status for breast cancer. Am J Epidemiol (2012) 1.21
Application of nonparametric quantile regression to body mass index percentile curves from survey data. Stat Med (2010) 1.20
Sunlight and other determinants of circulating 25-hydroxyvitamin D levels in black and white participants in a nationwide U.S. study. Am J Epidemiol (2013) 1.18
Cure fraction estimation from the mixture cure models for grouped survival data. Stat Med (2004) 1.18
Serum selenium and risk of prostate cancer in U.S. blacks and whites. Int J Cancer (2003) 1.17
Ethnicity is an independent correlate of biomarkers of micronutrient intake and status in American adults. J Nutr (2007) 1.17
Body size, dairy consumption, puberty, and risk of testicular germ cell tumors. Am J Epidemiol (2006) 1.17
Geographic variation in colorectal cancer survival and the role of small-area socioeconomic deprivation: a multilevel survival analysis of the NIH-AARP Diet and Health Study Cohort. Am J Epidemiol (2011) 1.16
Risk factors for classical Kaposi sarcoma in a population-based case-control study in Sicily. Cancer Epidemiol Biomarkers Prev (2008) 1.16
A comparative review of CISNET breast models used to analyze U.S. breast cancer incidence and mortality trends. J Natl Cancer Inst Monogr (2006) 1.15